A Shared Vision for More Inclusive, Scalable Trials

How trust-driven engagement and local partnerships expand access and improve trial performance

Clinical trials often struggle to reach diverse patient populations due to distance, access, and trust barriers. Learn how community-first research models help expand access, reduce patient burden, and improve enrollment and retention through local engagement.

Key takeaways include:

  • Why proximity matters for trial participation
  • How trust-driven community engagement improves access
  • The role of mobile visits in reducing dropout
  • How local partnerships support more inclusive enrollment

More Content

Read more related content below

Pharma Ignite Inspire. Connect. Innovate.
Powered by

Copyright ©️ 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company. Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.